Market Place
Sourcing Support
Sionna salvages AbbVie assets for assault on cystic fibrosis
16 Jul 2024 //
FIERCE BIOTECH
Samsung Biologics partners with LegoChem for ADC development and manufacturing
07 Feb 2024 //
PR NEWSWIRE
LegoChem, riding ADC sugar rush, raises $411M from sweet maker
16 Jan 2024 //
FIERCE BIOTECH
J&J jumps on ADC from LegoChem in deal that could pay out over $1 billion
27 Dec 2023 //
BUSINESSWIRE
LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC
25 Dec 2023 //
BUSINESSWIRE
LegoChem Selects BostonGene as Genomic Partner for First-in-Human Trial
07 Nov 2023 //
BUSINESSWIRE
LegoChem Biosciences Enters Worldwide Licensing Agreement with Glycotope
16 Oct 2023 //
GLOBENEWSWIRE
LegoChem licenses out ADC technology to Amgen in $1.2 billion deal
24 Dec 2022 //
BUSINESSWIRE
NextCure, LegoChem join big-league rivals in ADC race
16 Nov 2022 //
FIERCEBIOTECH
LegoChem, Glycotope Collaborate and License Agreement for Ab for use as ADC
11 Jul 2022 //
GLOBENEWSWIRE
Iksuda Deepens Clinical Pipeline Through Licensing Agreement From LegoChem
10 Jan 2022 //
BUSINESSWIRE
LegoChem Bio signs $1B deal with UK biotech
27 Dec 2021 //
KOREABIOMED
SOTIO expands its ADC pipeline via agreement with LegoChem
17 Nov 2021 //
THEPHARMALETTER
SOTIO, LegoChem Biosciences Enter ADC License Agreement
16 Nov 2021 //
CONTRACTPHARMA
SOTIO Expands its Antibody-Drug Conjugate Pipeline with Exclusive Collaboration
16 Nov 2021 //
GLOBENEWSWIRE
Antengene to collaborate with LegoChem Biosciences for antibody-drug conjugates
22 Oct 2021 //
PHARMATIMES
LegoChem Bioscience to co-develop ADC treatment with Chinese firm
11 Oct 2021 //
KOREABIOMED
Pyxis files for $100M IPO to take cancer drugs into the clinic
20 Sep 2021 //
FIERCEBIOTECH
LegoChem Biosciences and Iksuda Therapeutics expand License Agreement
22 Jun 2021 //
BUSINESSWIRE
Iksuda, LegoChem Expand ADC Alliance
22 Jun 2021 //
CONTRACTPHARMA
WuXi XDC and LegoChem Ink ADC Agreement
11 Jun 2021 //
CONTRACT PHARMA
WuXi XDC and LegoChem Biosciences Signed MoU for Antibody-drug Conjugates
09 Jun 2021 //
PRNEWSWIRE
PharmAbcine announces a research collaboration with LegoChem Biosciences
11 Jan 2021 //
PRNASIA
CStone and LegoChem to jointly develop novel antibody drug conjugate
30 Oct 2020 //
PHARMACEUTICAL-TECHNOLOGY
CStone inks deal worth $353.5M for new antibody drug conjugate
28 Oct 2020 //
BIOSPECTRUMASIA
LegoChem Biosciences and Iksuda Enter into a Multi-Target Research Collaboration
16 Apr 2020 //
BUSINESSWIRE
Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals
19 Jul 2019 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.